Analgesics

Consumption of analgesics continued to increase in Germany during 2023, after the demand spike in 2022, a year in which consumers were often experiencing flu and colds in the post-pandemic period and therefore OTC medicines, such as analgesics, were…

Analgesics has witnessed a return to positive volume growth in 2023, driven by the recovery of adult acetaminophen as a stronger flu season took hold in Switzerland. As the incidence of cold and flu increases, so does the use of analgesics in…

While sales of analgesics are seeing mid-single-digit growth in current value terms in 2023, sales have seen a steep decline in retail volume terms. The main reason for this disparity between value and volume growth in analgesics is the sharp rise in…

While its demographic profile remains one of the most youthful in Europe, Turkey is steadily aging, with a gradually rising median age of population. Turkish people are living longer, with life expectancy rising. As such, the growth in the…

Analgesics remained a key product area within consumer health in Sweden in 2023, having accounted for close to a quarter of overall OTC value sales. The most popular analgesics were those based on active ingredients acetaminophen or ibuprofen, with…

Since 2020, a factor supporting the growth of analgesics was the increased tendency of doctors to prescribe acetaminophen, among other common types of analgesics, as a way of managing the symptoms of patients with COVID-19, including muscle and joint…

Analgesics recorded a significant increase in retail volume terms in 2021 and this was followed by even more dynamic growth in 2022. The COVID-19 pandemic and the tough restrictions introduced in 2020 and the beginning of 2021 in order to prevent it…

Analgesics has experienced a fluctuating performance in the last few years, as demand has been significantly impacted by the dramatic changes to consumer lifestyles resulting from the COVID-19 crisis. With the outbreak of COVID-19 in 2020, many…

While most categories of analgesics are set to witness decreases in retail volume sales over 2023, this is largely due to spikes in sales in the wake of the Coronavirus (COVID-19) pandemic as stress and anxiety levels increased. In 2023, many…

Per capita consumption of analgesics continued to increase in Norway during 2023 after 2022 saw significant increases in consumption of these products. While there was some stockpiling of analgesics seen in Norway during the early stages of the…

Analgesics is expected to see a single-digit growth in current value terms in 2023. Sales are benefiting from the stable demand for analgesics and unit price increases linked to rising price lists as a result of the higher cost of production faced by…

Analgesics sales are returning to more normal patterns in 2023, following the fluctuations caused by the COVID-19 pandemic and the sharp price rises seen in 2022. On balance, current value growth rates are still elevated compared to pre-pandemic…

Upon the lifting of all COVID-19 related regulations, including the compulsory use of face masks, social distancing rules and compulsory self-isolation, there has been a surge in illness which has been a major contributor to sales growth for…

Value sales of analgesics in France continue to record solid growth in 2023 following a dynamic performance the previous year. The key growth driver is the increasing demand for acetaminophen, with the brand Doliprane from Sanofi, convincingly…

Following strong growth between 2020 and 2022, analgesics saw much more moderate current value growth in 2023 as the COVID-19 pandemic began to wane. Rising inflation as a result of the energy crisis stemming in part from the war in Ukraine is…

Sales of analgesics are seeing robust growth in current value terms in 2023, continuing on from the steady performance seen in 2022. During 2022, sales of analgesics benefited from a sudden peak in cases of flu in the middle of the winter. This was…

Analgesics is recording another strong year of current value growth in 2023, albeit at a slower rate than in 2022. Growth is particularly dynamic in the paediatric segment, especially for acetaminophen and ibuprofen, driven by the outbreak of…